You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Trial to test if cannabis-based mouth spray can treat brain tumours
- 2. Tuesday briefing: Brexit and Covid shortages ‘to get worse'
- 3. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
- 4. Urban–Rural Differences in Clinical Characteristics of Prostate Cancer at Initial Diagnosis: A Single-Center Observational Study in Anhui Province, China
- 5. Interference of COVID-19 Vaccination With PET/CT Leads to Unnecessary Additional Imaging in a Patient With Metastatic Cutaneous Melanoma—Case Report
- 6. Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus
- 7. RabbleHealth Appoints Former Kaiser Permanente Executive Mitch Ross to Advisory Board
- 8. Kintara has two promising oncology drug candidates with strong safety profiles in late-stage trials
- 9. Tecentriq wins FDA priority review for certain early NSCLC patients
- 10. Lutris Pharma Doses First U.S. Patients in Phase 2 Trial of LUT014 -- a Topical Gel for the Reduction of Dose-Limiting Acneiform Lesions -- in Metastatic Colorectal Cancer Patients Treated with EGFR Inhibitor Therapy
Last updated at 17:41 GMT
Hot News Makers
Health/Pharma Companies
-
35217.27
-
34012.21
-
22690.78
-
21023.20
-
20659.84
-
17616.48
-
16859.84
-
13862.34
-
12463.85
-
11587.30
Last updated at 17:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK